4.7 Article

A data-driven model of biomarker changes in sporadic Alzheimer's disease

Related references

Note: Only part of the references are listed.
Letter Biochemistry & Molecular Biology

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4

U. Andreasson et al.

MOLECULAR PSYCHIATRY (2014)

Review Neurosciences

Biomarker Modeling of Alzheimer's Disease

Clifford R. Jack et al.

NEURON (2013)

Article Clinical Neurology

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Susan M. Landau et al.

ANNALS OF NEUROLOGY (2012)

Review Medicine, Research & Experimental

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges

Jonathan W. Bartlett et al.

BIOMARKERS IN MEDICINE (2012)

Review Medicine, Research & Experimental

Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease

Karl Herholz

BIOMARKERS IN MEDICINE (2012)

Article Medicine, General & Internal

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Clinical Neurology

The pathological process underlying Alzheimer's disease in individuals under thirty

Heiko Braak et al.

ACTA NEUROPATHOLOGICA (2011)

Article Clinical Neurology

Longitudinal Change of Biomarkers in Cognitive Decline

Raymond Y. Lo et al.

ARCHIVES OF NEUROLOGY (2011)

Article Clinical Neurology

Evidence for Ordering of Alzheimer Disease Biomarkers

Clifford R. Jack et al.

ARCHIVES OF NEUROLOGY (2011)

Article Medicine, General & Internal

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Christopher M. Clark et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Review Clinical Neurology

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

Paul S. Aisen et al.

ALZHEIMERS & DEMENTIA (2010)

Article Clinical Neurology

Increased Brain Atrophy Rates in Cognitively Normal Older Adults with Low Cerebrospinal Fluid Aβ1-42

Jonathan M. Schott et al.

ANNALS OF NEUROLOGY (2010)

Review Clinical Neurology

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack et al.

LANCET NEUROLOGY (2010)

Review Clinical Neurology

The clinical use of structural MRI in Alzheimer disease

Giovanni B. Frisoni et al.

NATURE REVIEWS NEUROLOGY (2010)

Review Clinical Neurology

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Kaj Blennow et al.

NATURE REVIEWS NEUROLOGY (2010)

Article Geriatrics & Gerontology

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Christopher C. Rowe et al.

NEUROBIOLOGY OF AGING (2010)

Article Clinical Neurology

Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects

Leslie M. Shaw et al.

ANNALS OF NEUROLOGY (2009)

Review Radiology, Nuclear Medicine & Medical Imaging

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

Clifford R. Jack et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)

Article Clinical Neurology

Rates of cerebral atrophy differ in different degenerative pathologies

Jennifer L. Whitwell et al.

BRAIN (2007)

Letter Clinical Neurology

Apolipoprotein E genotype modifies the phenotype of Alzheimer disease

JM Schott et al.

ARCHIVES OF NEUROLOGY (2006)

Article Clinical Neurology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

WE Klunk et al.

ANNALS OF NEUROLOGY (2004)

Review Medicine, General & Internal

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

NC Fox et al.

LANCET (2004)

Review Clinical Neurology

CSF markers for incipient Alzheimer's disease

K Blennow et al.

LANCET NEUROLOGY (2003)

Article Multidisciplinary Sciences

Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI

RI Scahill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)